Using prognostic signatures and machine learning to identify core features associated with response to CDK4/6 inhibitor-based therapy in metastatic breast cancer
26 February 2025 at 08:00
Oncogene, Published online: 26 February 2025; doi:10.1038/s41388-025-03308-0
Using prognostic signatures and machine learning to identify core features associated with response to CDK4/6 inhibitor-based therapy in metastatic breast cancer